Edition:
United States

CymaBay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Capital Market

13.44USD
20 Apr 2018
Change (% chg)

$0.12 (+0.90%)
Prev Close
$13.32
Open
$13.22
Day's High
$13.56
Day's Low
$13.12
Volume
183,524
Avg. Vol
279,829
52-wk High
$15.59
52-wk Low
$3.16

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.20 December 23 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 6 6 6 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.75 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 7 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 7 0.00 0.00 0.00 0.00
Year Ending Dec-18 8 3.12 5.00 0.00 3.33
Year Ending Dec-19 8 8.88 36.00 0.00 30.00
Earnings (per share)
Quarter Ending Jun-18 7 -0.20 -0.17 -0.23 -0.31
Quarter Ending Sep-18 7 -0.24 -0.18 -0.41 -0.34
Year Ending Dec-18 7 -0.90 -0.65 -1.56 -0.98
Year Ending Dec-19 8 -0.93 -0.18 -1.51 -0.19

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 1.25 5.21 3.96 316.56
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 4.79 4.79 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 3.12 3.75 3.75 2.50 3.33
Year Ending Dec-19 8.88 8.88 8.88 11.38 30.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 1 0 1
Year Ending Dec-19 0 0 0 0
Earnings